HomeAbout

TL;DR CNBC


Moderna stock falls by as much as 9.4% after report says late-stage coronavirus vaccine trial delayed - TL;DR CNBC

Moderna stock falls by as much as 9.4% after report says late-stage coronavirus vaccine trial delayed

Publishing timestamp: 2020-07-02 17:05:47


Summary


Sentiment: NEGATIVE

Tickers: MRNA

Keywords:

Source: https://www.cnbc.com/2020/07/02/moderna-stock-falls-8percent-after-report-says-late-stage-coronavirus-vaccine-trial-delayed.html


Developed by Leo Phan